Wednesday, 26 August 2026European Markets

BOURSE DIRECT Stock Bullish Momentum With A 9.66% Rise On Tuesday

Loading stream...

(vianews) - the market ended the session with bourse direct (bsd.pa) jumping 9.66% to €4.20 on tuesday while cac 40 jumped 1.42% to €7,112.91.

bourse direct's last close was €3.83, 9.24% under its 52-week high of €4.22.

about bourse direct

bourse direct sa provides internet stock brokerage services in france. it offers a platform of services, tools, and financial products, including french and foreign equities, derivatives, trackers, warrants, certificates, turbos, mutual funds, ucits, and cfds, as well as tax exemption, retirement, real estate, and life insurance products through the boursedirect.fr, capitol.fr, tradebox.fr, abssysteme.fr, wargny.com, and mesactions.com sites. the company was founded in 1996 and is headquartered in paris, france. bourse direct sa is a subsidiary of e-viel sa.

earnings per share

as for profitability, bourse direct has a trailing twelve months eps of €0.13.

pe ratio

bourse direct has a trailing twelve months price to earnings ratio of 32.31. meaning, the purchaser of the share is investing €32.31 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.29%.

moving average

bourse direct's worth is way higher than its 50-day moving average of €3.70 and way above its 200-day moving average of €3.32.

more news about bourse direct (bsd.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com